NCT07497074: JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer
- State
- Not started
- Phase
- Phase 2
- People
- 78 planned
- Started
- Apr 2026
- Primary completion
- Oct 2027
- Arms
- Safety run-in dose cohort 1, Safety run-in dose cohort 2, Dose expansion cohort
- Results
- None posted
- 27 Mar 2026: Trial registered